Valuation: Repligen Corporation

Market Cap 9.38B 8.04B 7.51B 6.89B 12.96B 896B 13.17B 88.62B 34.7B 449B 35.21B 34.44B 1,486B P/E 2026 *
220x
P/E 2027 * 96x
Enterprise Value 9.14B 7.84B 7.32B 6.72B 12.64B 874B 12.84B 86.42B 33.84B 438B 34.33B 33.58B 1,449B EV / Sales 2026 *
11.1x
EV / Sales 2027 * 9.25x
Free-Float
94.32%
Yield 2026 *
-
Yield 2027 * -
1 day+5.71%
1 week+5.81%
Current month+24.33%
1 month+20.50%
3 months+61.56%
6 months+27.77%
Current year+6.99%
1 week 161.9
Extreme 161.895
179.87
1 month 129
Extreme 129
179.87
Current year 100.99
Extreme 100.99
179.87
1 year 100.99
Extreme 100.99
179.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap.
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
6/25/26 Sell

Chief Financial Officer

-733 0.0013%
5/14/26 Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+5.67%+5.81%+41.96%+8.91% 9.38B
+1.86%+3.62%-12.43%+10.65% 195B
+1.48%+3.17%+4.16%+14.74% 118B
+0.37%+0.65%+7.30%+74.73% 60.33B
-3.33%-3.18%+29.54%+64.34% 55.1B
+2.98%+1.47%-5.93%-32.41% 49.24B
-0.11%-1.48%+10.58%-14.54% 33.81B
-0.63%-4.08% - - 29.94B
+1.94%+0.45%+43.28%-9.88% 24.39B
-4.11%-4.02%-11.35%+19.85% 23.82B
Average +0.62%-0.42%+11.90%+15.15% 59.89B
Weighted average by Cap. +0.86%+0.47%+2.42%+17.74%

Financials

2026 *2027 *
Net sales 827M 709M 662M 608M 1.14B 79.05B 1.16B 7.82B 3.06B 39.65B 3.11B 3.04B 131B 969M 831M 776M 712M 1.34B 92.64B 1.36B 9.16B 3.59B 46.46B 3.64B 3.56B 154B
Net income 41.92M 35.96M 33.58M 30.81M 57.93M 4.01B 58.89M 396M 155M 2.01B 157M 154M 6.64B 98.84M 84.79M 79.17M 72.64M 137M 9.45B 139M 934M 366M 4.74B 371M 363M 15.67B
Net Debt -234M -200M -187M -172M -323M -22.33B -328M -2.21B -865M -11.2B -877M -858M -37.03B -407M -349M -326M -299M -563M -38.93B -572M -3.85B -1.51B -19.53B -1.53B -1.5B -64.56B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-08-19 $175.30 +5.50% 1,043,615
26-08-18 $166.15 -1.71% 462,720
26-08-17 $169.04 +1.32% 658,901
26-08-14 $166.83 -0.39% 598,130
26-08-13 $167.49 +1.08% 762,300
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
166.15USD
Average target price
185.70USD
Spread / Average Target
+11.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock